Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipopolysaccharide antagonists.

W A Lynn1, D T Golenbock

  • 1Dept of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston City Hospital, Boston University School of Medicine, MA 02118.

Immunology Today
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MyD88-dependent pathway is essential for the innate immunity to Enterocytozoon bieneusi.

Parasite immunology·2011
Same author

The wandering eye: eye infection in the returning traveller.

Travel medicine and infectious disease·2007
Same author

The eye in systemic infection.

Lancet (London, England)·2004
Same author

Uveitis in a patient receiving rifabutin for Crohn's disease.

Journal of the Royal Society of Medicine·2004
Same author

Syphilis and HIV: a dangerous combination.

The Lancet. Infectious diseases·2004
Same author

Clinical microbiological case: visual problems in an HIV-positive patient.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2001
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Bacterial lipopolysaccharide (LPS) triggers immune cells and causes Gram-negative infections. Identifying LPS antagonists and receptors is key to understanding immune activation and developing new anti-LPS therapies.

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Bacterial lipopolysaccharide (LPS) is a key immune stimulant.
  • LPS plays a critical role in Gram-negative bacterial infection pathogenesis.
  • The toxic effects of LPS are attributed to its lipid A component.

Purpose of the Study:

  • To investigate the role of LPS in immune cell activation.
  • To identify LPS receptors and their antagonists.
  • To explore novel anti-LPS therapeutic strategies.

Main Methods:

  • Analysis of structural analogs and precursors of lipid A.
  • Investigating competitive antagonists of LPS.
  • Characterizing LPS-receptor interactions.

Related Experiment Videos

Main Results:

  • Structural analogs of lipid A act as competitive antagonists of LPS.
  • The existence of specific LPS receptors is strongly supported.
  • LPS antagonists aid in defining cellular activation pathways.

Conclusions:

  • LPS receptor identification is crucial for understanding immune responses.
  • LPS antagonists offer potential for developing new antibacterial therapies.
  • Targeting LPS-receptor interactions can lead to novel anti-LPS strategies.